/People

James Pipkin

Investor

Vice President, New Product Development at Ligand Pharmaceuticals

Find your path to James

21 people in our graph can introduce you to James.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Richard Heyman to introduce you to James

You →Richard · together at Ligand Pharmaceuticals →James

Ask Jamie Chen to introduce you to James

You →Jamie · 11 people · together at Ligand Pharmaceuticals →James

Sign up to find every way you can get introduced to James

  • Your email: the people you already email who know James
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with James
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

VP of New Product Development focused on new applications and IP for the Captisol cyclodextrin drug-delivery technology. He joined via the 2011 CyDex acquisition and previously led CMC services at Oread Laboratories.

Colleagues at Ligand Pharmaceuticals

Frequently asked questions

Who is James Pipkin?
VP of New Product Development focused on new applications and IP for the Captisol cyclodextrin drug-delivery technology. He joined via the 2011 CyDex acquisition and previously led CMC services at Oread Laboratories.
Where does James Pipkin work?
James Pipkin is Vice President, New Product Development at Ligand Pharmaceuticals.